We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Newly Identified Oncogene Links Amino Acids to Colorectal Cancer Development

By LabMedica International staff writers
Posted on 02 Nov 2014
Print article
Cancer researchers have identified a novel oncogene—and possible drug target—that promotes development of colorectal cancer by interacting with amino acids to activate the pro-cancer mTORC1 signaling complex.

mTOR (mammalian target of rapamycin) is a master regulator of protein synthesis that under ordinary conditions induces cells to grow and divide. In situations of severe nutrient deprivation mTOR closes down protein synthesis so that the cell can conserve energy. However, in cancer cells the mTOR pathway misfires and signals tumor cells to grow, divide, undergo metastasis, and invade new, healthy tissues.

Investigators at Rutgers University (New Brunswick, NJ, USA) have been looking at the interaction between amino acids and the small GTPase enzyme Rab1A, which is a key switch for amino acid signaling.

They reported in the October 13, 2014, online edition of the journal Cancer Cell that amino acids activated Rab1A, which then stimulated Rheb (another small GTPase) to interact with the mTORC1 complex in the cells' Golgi apparatus. They found that Rab1A overexpression promoted mTORC1 signaling and oncogenic growth in an amino acid- and mTORC1-dependent manner. Blocking Rab1A activity selectively inhibited oncogenic growth of Rab1-overexpressing cancer cells. Furthermore, Rab1A was found to be overexpressed in colorectal cancer, which was correlated with elevated mTORC1 signaling, tumor invasion, progression, and poor prognosis. In contrast, overexpression of Rab1A increased sensitivity of cancer cells toward the drug rapamycin, which blocks the growth-stimulating effect of mTORC1.

Senior author Dr. X. F. Steven Zheng, professor of pharmacology at Rutgers University, said, “In further elucidating the role Rab1A plays in amplifying amino acid signaling, we can further understand this impact on the mTORC1 protein. Especially since elevated levels of mTORC1 signaling is found in colorectal cancer, new therapy options targeted toward mTORC1 can be explored.”

Related Links:

Rutgers University



New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.